BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 2568350)

  • 1. Double-blind placebo cross-over study of long-acting (chlordesmethyldiazepam) versus short-acting (lorazepam) benzodiazepines in generalized anxiety disorders.
    Bertin I; Colombo G; Furlanut M; Benetello P
    Int J Clin Pharmacol Res; 1989; 9(3):203-8. PubMed ID: 2568350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind cross-over clinical comparison of two 2'-chloro benzodiazepines: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (chlordesmethyldiazepam) versus 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in neurotic anxiety.
    Andreoli V; Maffei F; Montanaro N; Morandini G
    Arzneimittelforschung; 1977 Feb; 27(2):436-9. PubMed ID: 16622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychosedative effect of chlordesmethyldiazepam on anxiety states in neurotic and psychotic inpatients.
    Paradiso L; Rapisarda V
    Clin Ther; 1980; 3(3):194-9. PubMed ID: 6109567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does chlordesmethyldiazepam have a specific anti-erotic effect? Report on five observations.
    Cocchi R; Passanisi S; Macci F
    Acta Psychiatr Belg; 1982; 82(6):555-64. PubMed ID: 6134427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Premedication for endoscopic examinations with intravenous administration of chlordesmethyldiazepam. A controlled double-blind study with diazepam and placebo].
    Fichera G; Germiniani R; Siardi C; Granelli P; De Ruberto F
    Minerva Dietol Gastroenterol; 1987; 33(2):141-7. PubMed ID: 2888055
    [No Abstract]   [Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices.
    Zung WW; Daniel JT; King RE; Moore DT
    J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
    Diamond BI; Nguyen H; O'Neal E; Ochs R; Kaffeman M; Borison RL
    Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two dosages of chlordesmethyldiazepam on mnestic-information processes in normal subjects.
    Scarone S; Strambi LF; Cazzullo CL
    Clin Ther; 1981; 4(3):184-91. PubMed ID: 6796270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug.
    Fischer-Cornelssen KA
    Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL; Parmley LF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
    Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related multiple-dose pharmacokinetics and anxiolytic effects of delorazepam (chlordesmethyldiazepam).
    Bareggi SR; Nielsen NP; Leva S; Pirola R; Zecca L; Lorini M
    Int J Clin Pharmacol Res; 1986; 6(4):309-14. PubMed ID: 2875955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and metabolite pattern of tetrazepam and chlordesmethyldiazepam].
    Staak M; Sticht G; Käferstein H; Norpoth T
    Beitr Gerichtl Med; 1984; 42():75-9. PubMed ID: 6148069
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndrome.
    Laakmann G; Blaschke D; Hippius H; Schewe S
    Pharmacopsychiatry; 1989 May; 22(3):120-5. PubMed ID: 2568645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and therapy of delirium tremens with tiapride and chlordesmethyldiazepam].
    Cazzato G; Gioseffi M; Torre P; Coppola N
    Riv Neurol; 1982; 52(6):331-42. PubMed ID: 6130594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.